← Leaderboards
Gary A Peltz
Roche Palo Alto, Llc
$31,742,929
Attributed
$33,882,599
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,882,599 · 12
By mechanism
R01$20,690,844 · 7
U19$4,982,119 · 1
U01$4,688,087 · 1
R24$2,289,285 · 1
R56$1,232,264 · 2
Top collaborators
- David Raymond Drover6 shared
Others in their field
Top investigators on “Alleles”
- Richard A Gibbs · Baylor College Of Medicine$162,061,189
- Eric S Lander · Whitehead Institute For Biomedical Res$88,310,092
- Kc Kent Lloyd · University Of California At Davis$73,526,404
- Michael A Province · Washington University$68,289,985
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard J O'Reilly · Sloan-Kettering Institute For Cancer Res$51,945,604
Research focus
AllelesGeneticEngineeringPharmaceutical PreparationsGenesAffectGene ExpressionBaseCostDoseDrug MetabolismPublic HealthPhenotypeGenome EngineeringPreventionResponseLiverGenetic VariantTissuesInbred StrainComputerized ToolsTraitAddictionExperimental Study
Grant awards (51)
Enabling AI-based Mouse Genetic Discovery$747,066
R24 · FY2025 · OD · contact PI
AI-based genetic discovery for hearing loss$614,664
R01 · FY2025 · DC · contact PI
Enabling AI-based Mouse Genetic Discovery$762,512
R24 · FY2024 · OD · contact PI
AI-based genetic discovery for hearing loss$635,552
R01 · FY2024 · DC · contact PI
Enabling AI-based Mouse Genetic Discovery$779,707
R24 · FY2023 · OD · contact PI
AI-based genetic discovery for hearing loss$659,597
R01 · FY2023 · DC · contact PI
A Model for Human Liver Fibrosis$772,327
R56 · FY2022 · DK · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$154,563
U01 · FY2022 · DA · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$639,431
U01 · FY2021 · DA · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$13,878
U01 · FY2021 · DA · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$639,431
U01 · FY2020 · DA · contact PI
Prevention of neonatal opioid withdrawal syndrome$582,442
R01 · FY2020 · HD · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$126,927
U01 · FY2020 · DA · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$878,896
U01 · FY2019 · DA · contact PI
Chimeric Mice: Improving Drug Safety$668,214
R01 · FY2019 · DK · contact PI
Prevention of neonatal opioid withdrawal syndrome$595,002
R01 · FY2019 · HD · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$8,467
U01 · FY2019 · DA · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$1,181,301
U01 · FY2018 · DA · contact PI
Chimeric Mice: Improving Drug Safety$661,046
R01 · FY2018 · DK · contact PI
Prevention of neonatal opioid withdrawal syndrome$646,029
R01 · FY2018 · HD · contact PI
Pharmacology Core$1,321,810
U19 · FY2017 · AI · contact PI
Computational Methods for Identification of Genetic Factors Affecting the Response to Drug Abuse$1,045,193
U01 · FY2017 · DA · contact PI
Chimeric Mice: Improving Drug Safety$631,416
R01 · FY2017 · DK · contact PI
Stem Cell-Based In vivo Models of Human Genetic Liver Diseases$547,988
R01 · FY2017 · DK · contact PI
Prevention of Neonatal Abstinence Syndrome$233,962
R01 · FY2017 · HD · contact PI
Pharmacology Core$1,294,254
U19 · FY2016 · AI · contact PI
Prevention of Neonatal Abstinence Syndrome$810,655
R01 · FY2016 · HD · contact PI
Chimeric Mice: Improving Drug Safety$592,184
R01 · FY2016 · DK · contact PI
Stem Cell-Based In vivo Models of Human Genetic Liver Diseases$548,072
R01 · FY2016 · DK · contact PI
Pharmacology Core$1,270,083
U19 · FY2015 · AI · contact PI
Prevention of Neonatal Abstinence Syndrome$805,666
R01 · FY2015 · HD · contact PI
Stem Cell-Based In vivo Models of Human Genetic Liver Diseases$588,654
R01 · FY2015 · DK · contact PI
Human Pharmacogenetics and Human Liver Regeneration$1,266,961
R01 · FY2014 · DK · contact PI
Pharmacology Core$1,095,972
U19 · FY2014 · AI · contact PI
Prevention of Neonatal Abstinence Syndrome$803,084
R01 · FY2014 · HD · contact PI
Human Pharmacogenetics and Human Liver Regeneration$1,228,953
R01 · FY2013 · DK · contact PI
Prevention of Neonatal Abstinence Syndrome$783,605
R01 · FY2013 · HD · contact PI
Human Pharmacogenetics and Human Liver Regeneration$1,266,961
R01 · FY2012 · DK · contact PI
Prevention of Neonatal Abstinence Syndrome$842,368
R01 · FY2012 · HD · contact PI
Human Pharmacogenetics and Human Liver Regeneration$1,266,961
R01 · FY2011 · DK · contact PI
Human Pharmacogenetics and Human Liver Regeneration$406,854
R01 · FY2011 · DK · contact PI
Human Pharmacogenetics and Human Liver Regeneration$957,500
R01 · FY2010 · DK · contact PI
Pharmacogenetic Analysis in Mice (II)$459,937
R56 · FY2007 · GM · contact PI
Pharmacogenetic Analysis in Mice$290,533
R01 · FY2006 · GM · contact PI
Pharmacogenetic Analysis in Mice$288,917
R01 · FY2005 · GM
Pharmacogenetic Analysis in Mice$280,560
R01 · FY2004 · GM
NOVEL SNP-ALLELE GENOTYPING METHOD$309,327
R01 · FY2002 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$61,000
R01 · FY2002 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$297,793
R01 · FY2001 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$121,136
R01 · FY2001 · HG
NOVEL SNP-ALLELE GENOTYPING METHOD$397,188
R01 · FY2000 · HG